Patients must have measurable or evaluable disease
Participants must have measurable or evaluable disease
Radiologically measurable or clinically evaluable disease
Patients must have measurable or evaluable disease
Patients must have measurable or evaluable disease
Part A: Patients must have either measurable or evaluable disease
Parts A & C: patients must have either measurable or evaluable disease
Parts B, D & E: patients must have measurable disease for Parts B1-B6, D1-D5, E3 and E4; melanoma patients in Part B7 must have either measurable or evaluable disease; neuroblastoma patients in Parts B8 and D6 must be evaluable for MIBG response without evidence of RECIST measurable lesions
Disease status:* Part A: Patients must have either measurable or evaluable disease* Parts B and C: Patients must have measurable disease on imaging
CA-125 only disease without RECIST 1.1 measurable or otherwise evaluable disease
Patients must have measurable or evaluable disease
Patients must have either measurable or evaluable disease
Patients must have either measurable or evaluable disease
Patients must have either measurable or evaluable disease
Patients must have measurable or evaluable disease
Patients must have either measurable or evaluable disease
